E 275mg / H 75mg / R 150mg, tab., blister
STD
DORAEHRI1T1
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
12/04/2024, 17:46:18
Former
Code(s):
DORARHEF01T
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J04AM07
Anatomical Therapeutic Chemical Classification according to WHOCC
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
ETHAMBUTOL (E) / ISONIAZID (H) / RIFAMPICIN (R)
Therapeutic Action
Fixed-dose combination (FDC) of two antituberculosis bactericidals and one antituberculosis bacteriostatic (ethambutol)
Indications
Drug-Sensitive tuberculosis (DS-TB)
Instructions for use
Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.
Bulk packaging (hospital packs) should only be used in special circumstances or in case of unexpected problems in availability of the blister presentation.
The quantity to be ordered is calculated per tablet, not per blister.
Storage
Below 25°C ‐ Protect from sunlight ‐ Protect from humidity